Home > Journals > The Journal of Cardiovascular Surgery > Past Issues > The Journal of Cardiovascular Surgery 2018 August;59(4) > The Journal of Cardiovascular Surgery 2018 August;59(4):512-25

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

REVIEW  EVOLVING TECHNOLOGIES FOR INFRA-INGUINAL ARTERIAL DISEASE 

The Journal of Cardiovascular Surgery 2018 August;59(4):512-25

DOI: 10.23736/S0021-9509.18.10599-4

Copyright © 2018 EDIZIONI MINERVA MEDICA

language: English

The use of drug-coated balloons in the treatment of femoropopliteal and infrapopliteal disease

Jun LI 1, 2, Adham KARIM 1, Mehdi H. SHISHEHBOR 1, 2

1 Division of Cardiovascular Medicine, Department of Interventional Cardiology, Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Cleveland, OH, USA; 2 Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, USA


PDF


While the field of endovascular interventions has evolved in the last decade, technological advancements have rendered drug-coated balloons (DCBs) to be the first line therapy for femoropopliteal artery disease. As the knowledge continues to advance, the application of DCB to the infrapopliteal segments as well as its role in in conjunction with plaque modification to minimize stent utilization, will be further elucidated.


KEY WORDS: Balloon angioplasty - Femoral artery - Popliteal artery - Peripheral arterial disease

top of page